SLC5A5 and thyroid cancer: Background: Sodium/iodide symporter (NIS) expression is frequently downregulated and/or shows diminished targeting to the plasma membrane in differentiated thyroid cancer, resulting in suboptimal radioiodine treatment and poor prognosis.